Agile Therapeutics Inc.

NASDAQ: AGRX · Real-Time Price · USD
1.51
0.05 (3.42%)
At close: Aug 22, 2024, 9:58 PM

Agile Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.56M 5.25M 19.14M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
238K 2.01M 2.01M
Receivables
3.39M 3.38M 1.53M
Inventory
2.74M 1.33M 966K
Other Current Assets
402K 1.4M 2.28M
Total Current Assets
9.53M 11.36M 23.93M
Property-Plant & Equipment
487K 872K 13.4M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
725K 2.88M 15.41M
Total Assets
10.26M 14.24M 39.33M
Account Payables
9.57M 7.73M 8.71M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
1.71M 1.75M 17.01M
Other Current Liabilities
832K 514K 1.91M
Total Current Liabilities
20.78M 13.39M 29.28M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
5.7M 5.93M 5.36M
Total Long-Term Liabilities
5.8M 6.4M 784K
Total Liabilities
26.57M 19.79M 30.06M
Total Debt
2.17M 2.21M 17.79M
Common Stock
4K 4K 12K
Retained Earnings
-423.17M -408.7M -387.12M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
-16.32M -5.54M 9.27M
Total Investments
n/a n/a n/a